SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for GHRS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 24.75M
March 31, 2026 23.44M
December 31, 2025 21.95M
September 30, 2025 21.36M
June 30, 2025 19.59M
March 31, 2025 17.31M
December 31, 2024 15.30M
September 30, 2024 13.47M
June 30, 2024 11.87M
March 31, 2024 11.16M
December 31, 2023 11.40M
September 30, 2023 10.76M
June 30, 2023 10.13M
March 31, 2023 9.891M
Date Value
December 31, 2022 10.07M
September 30, 2022 11.08M
June 30, 2022 11.18M
March 31, 2022 9.391M
December 31, 2021 6.547M
September 30, 2021 3.277M
June 30, 2021 1.167M
March 31, 2021 0.448M
December 31, 2020 0.00
September 30, 2020 0.00
June 30, 2020 0.00
March 31, 2020 0.00
December 31, 2019 0.00

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Atai Beckley, Inc. 71.80M
Avadel Pharmaceuticals Plc 191.46M
Jazz Pharmaceuticals Plc 1.679B
Eli Lilly & Co. 12.24B
Perrigo Co. Plc 997.20M